ArticleJournal of clinical medicine2024
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study.
Abstract read
In one paragraph
Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Real-World Evidence.Allergy · 2025Pooled it
- Is Asthma Remission a New Achievable Goal? A Review of the Current Drug-Related Evidence and Predictors.Allergy · 2026Review
- A four-year journey towards clinical remission and background therapies optimization with benralizumab: A retrospective analysis.The World Allergy Organization journal · 2026Article
- Clinical remission and associated factors in severe eosinophilic asthma patients treated with benralizumab: a real-world study.BMC pulmonary medicine · 2026Article
- Review
- Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.Journal of clinical medicine · 2026Article
- Modifying the course of asthma: mechanisms and strategies for clinical remission.Current opinion in allergy and clinical immunology · 2026Review
- Clinical remission in patients with severe eosinophilic asthma treated with benralizumab over 24 months: Post hoc analysis of the ANANKE study.The World Allergy Organization journal · 2026Article
- Is blood eosinophilia a treatable trait in chronic obstructive airway diseases?Frontiers in immunology · 2026Review
- Asthma and corticosteroids "Frontiers in allergy · 2026Review
- Benralizumab in Severe Eosinophilic Asthma: Toward Disease Control and Evolving Treatment Paradigms.Journal of inflammation research · 2026Review
- Role of IL-5 in eosinophil-associated diseases and prospects for multi-target therapy.Frontiers in immunology · 2026Review
- Benralizumab-Induced Asthma Remission: Impact of Different Tools and Thresholds to Define Good Asthma Control.Respiration; international review of thoracic diseases · 2026Article
- Predictive Factors And Treatments Associated with Clinical Remission in Severe Eosinophilic Asthma.Journal of inflammation research · 2026Review
- Article
- Immunotherapy for asthma.Cellular & molecular immunology · 2025Review
- Long-term effectiveness and safety of benralizumab in EGPA: a 3-year single-center experience.Annals of medicine · 2025Article
- Future Risk After Achieving Clinical Remission in Patients with Severe Asthma: A Comparison of Different Definitions.Journal of clinical medicine · 2025Article
- Osteoporosis in Severe Asthmatic Patients: Data from the Severe Asthma Network in Italy (SANI) Registry.Journal of clinical medicine · 2025Article
- Unraveling the mechanisms of virus-induced asthma exacerbation: epithelial injury, immune dysregulation, and novel interventions.Chinese medical journal pulmonary and critical care medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Laura PiniASST Spedali Civili of Brescia, 25123 Brescia, Italy.ORCID 0000-0001-6563-4942
Diego BagnascoAllergy and Respiratory Diseases Clinic, IRCCS Policlinico San Martino, 16132 Genova, Italy.
Bianca BeghèDepartment of Medical and Surgical Sciences, Maternal, Infant and Adult, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Fulvio BraidoAllergy and Respiratory Diseases Clinic, IRCCS Policlinico San Martino, 16132 Genova, Italy.
Paolo CameliRespiratory Diseases Unit, Department of Medical Sciences, Azienda Ospedaliera-Universitaria Senese, 53100 Siena, Italy.ORCID 0000-0001-8639-2882
Marco CaminatiDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0001-7383-1487
Cristiano CarusoAllergologic Unit, Policlinico Agostino Gemelli, 00168 Rome, Italy.ORCID 0000-0001-7631-029X
Claudia CrimiRespiratory Medicine Unit, Policlinico "G. Rodolico-San Marco" University Hospital, 95123 Catania, Italy.ORCID 0000-0002-9088-5214
Gabriella GuarnieriDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padova, 35122 Padova, Italy.ORCID 0000-0003-3664-2024
Manuela LatorrePneumologic Unit, Department of Medical Specialties, Nuovo Ospedale delle Apuane, 54100 Massa, Italy.
Francesco MenzellaPneumologic Unit, Ospedale di Montebelluna, 31044 Montebelluna, Italy.ORCID 0000-0003-3950-5789
Claudio MichelettoPneumologic Unit, Ospedale Borgo Trento, 37126 Verona, Italy.ORCID 0000-0002-1138-3882
Andrea VianelloDepartment of Cardiac, Thoracic and Vascular Sciences, University of Padova, 35122 Padova, Italy.ORCID 0000-0002-8790-6029
Dina ViscaDepartment of Medicine and Surgery, Respiratory Diseases, University of Insubria, 21100 Varese, Italy.
Benedetta BondiAllergy and Respiratory Diseases Clinic, IRCCS Policlinico San Martino, 16132 Genova, Italy.
Yehia El MasriDepartment of Clinical and Experimental Sciences, University of Brescia, 25122 Brescia, Italy.
Jordan GiordaniDepartment of Clinical and Experimental Sciences, University of Brescia, 25122 Brescia, Italy.ORCID 0000-0002-5958-0228
Andrea MastrototaroDepartment of Medicine, University of Verona, 37134 Verona, Italy.
Matteo MauleAsthma Center and Allergy Unit, Verona University Hospital, 37126 Verona, Italy.
Alessandro PiniDepartment of Emergency, Anaesthesiological and Resuscitation Sciences, University Cattolica Sacro Cuore, 29122 Rome, Italy.
Stefano PirasDepartment of Clinical and Experimental Sciences, University of Brescia, 25122 Brescia, Italy.
Martina ZappaDepartment of Medicine and Surgery, Respiratory Diseases, University of Insubria, 21100 Varese, Italy.ORCID 0000-0001-8443-5316
Gianenrico SennaDepartment of Medicine, University of Verona, 37134 Verona, Italy.ORCID 0000-0003-4172-3216
Antonio SpanevelloDepartment of Medicine and Surgery, Respiratory Diseases, University of Insubria, 21100 Varese, Italy.
Pierluigi PaggiaroDepartment of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, 56124 Pisa, Italy.
Francesco BlasiDepartment of Pathophysiology and Transplantation, University of Milano, 20122 Milan, Italy.ORCID 0000-0002-2285-9970
Giorgio Walter CanonicaPersonalized Medicine Center, Asthma and Allergology, Humanitas Research Hospital, 20089 Rozzano, Italy.
On Behalf Of The Sani Study Group
Funding
AstraZeneca (Italy) N/A
Abstract
PubMed holds no abstract for this paper.
Indexed as
benralizumabclinical remissioneffectivenesslong termsevere eosinophilic asthma
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.